Cargando…
A Systematic Review of the Clinical Efficacy and Safety of CFTR Modulators in Cystic Fibrosis
Several placebo-controlled trials have been recently published evaluating novel therapies targeting the defective CFTR protein. This systematic review examines the clinical efficacy and safety of CFTR modulators in individuals with cystic fibrosis (CF) with specific genetic mutations. Online sources...
Autores principales: | Habib, Al-Rahim R., Kajbafzadeh, Majid, Desai, Sameer, Yang, Connie L., Skolnik, Kate, Quon, Bradley S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510767/ https://www.ncbi.nlm.nih.gov/pubmed/31076617 http://dx.doi.org/10.1038/s41598-019-43652-2 |
Ejemplares similares
-
Real-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review
por: Dagenais, Renée V. E., et al.
Publicado: (2020) -
Nontuberculous Mycobacteria in Cystic Fibrosis
por: Skolnik, Kate, et al.
Publicado: (2016) -
Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations
por: Skolnik, Kate, et al.
Publicado: (2018) -
Experience to date with CFTR modulators during pregnancy and breastfeeding in the British Columbia Cystic Fibrosis clinic
por: Goodwin, Jodi, et al.
Publicado: (2022) -
Correction: Dagenais et al. Real-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review. J. Clin. Med. 2021, 10, 23
por: Dagenais, Renée V. E., et al.
Publicado: (2022)